Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults

Chien Yu Lin, Lian Yu Lin, Ting Wen Wen, Guang Wen Lien, Kuo Liong Chien, Sandy H J Hsu, Chien Chang Liao, Fung Chang Sung, Pau Chung Chen, Ta Chen Su

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

Background Perfluorinated chemicals (PFCs) have been widely used for years in a variety of products worldwide. Although epidemiological findings have shown that PFC levels are positively associated with cholesterol and uric acid levels, it is unknown whether PFCs are associated with atherosclerosis. Methods We recruited 664 subjects (12-30 years) from a population-based sample of adolescents and young adults based on a mass urine screening to determine the relationship between serum levels of PFCs and carotid intima-media thickness (CIMT). Results The median concentrations and ranges of perfluorooctanoic acid (PFOA), perfluorooctane sulfate (PFOS), perfluorononanoic acid (PFNA), and perfluorodecanoic acid (PFUA) were 3.49 (0.75-52.2) ng/mL, 8.65 (0.11-85.90) ng/mL, 0.38 (0.38-25.4) ng/mL, and 6.59 (1.50-105.7) ng/mL, respectively. After controlling for age, gender, smoking status, systolic blood pressure, body mass index, low-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, and homeostasis model assessment of insulin resistance, multiple linear regression analysis revealed that CIMT increased significantly across quartiles of PFOS (0.434 mm, 0.446 mm, 0.458 mm, 0.451 mm; P for trend <0.001). Subpopulation analysis showed the association between PFOS and CIMT was more evident and significant in females, non-smokers, subjects of age 12-19 years, BMI <24, and those with APOE genotype of E2 carrier and E3/E3. Conclusions Higher serum concentrations of PFOS were associated with an increase of carotid IMT in this cohort of adolescents and young adults. Further studies are warranted to clarify the causal relationship between PFOS and atherosclerosis.

Original languageEnglish
Pages (from-to)3309-3316
Number of pages8
JournalInternational Journal of Cardiology
Volume168
Issue number4
DOIs
Publication statusPublished - Oct 9 2013

Fingerprint

Carotid Intima-Media Thickness
Carotid Arteries
Sulfates
Young Adult
Serum
perfluorooctanoic acid
Atherosclerosis
Blood Pressure
Mass Screening
Uric Acid
C-Reactive Protein
LDL Cholesterol
Insulin Resistance
Linear Models
Body Mass Index
Homeostasis
Smoking
Cholesterol
Genotype
Regression Analysis

Keywords

  • Carotid intima-media thickness
  • Perfluorinated chemicals
  • Perfluorononanoic acid
  • Perfluorooctane sulfate

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults. / Lin, Chien Yu; Lin, Lian Yu; Wen, Ting Wen; Lien, Guang Wen; Chien, Kuo Liong; Hsu, Sandy H J; Liao, Chien Chang; Sung, Fung Chang; Chen, Pau Chung; Su, Ta Chen.

In: International Journal of Cardiology, Vol. 168, No. 4, 09.10.2013, p. 3309-3316.

Research output: Contribution to journalArticle

Lin, Chien Yu ; Lin, Lian Yu ; Wen, Ting Wen ; Lien, Guang Wen ; Chien, Kuo Liong ; Hsu, Sandy H J ; Liao, Chien Chang ; Sung, Fung Chang ; Chen, Pau Chung ; Su, Ta Chen. / Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults. In: International Journal of Cardiology. 2013 ; Vol. 168, No. 4. pp. 3309-3316.
@article{40929526406a47df93c072cb3c43a73c,
title = "Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults",
abstract = "Background Perfluorinated chemicals (PFCs) have been widely used for years in a variety of products worldwide. Although epidemiological findings have shown that PFC levels are positively associated with cholesterol and uric acid levels, it is unknown whether PFCs are associated with atherosclerosis. Methods We recruited 664 subjects (12-30 years) from a population-based sample of adolescents and young adults based on a mass urine screening to determine the relationship between serum levels of PFCs and carotid intima-media thickness (CIMT). Results The median concentrations and ranges of perfluorooctanoic acid (PFOA), perfluorooctane sulfate (PFOS), perfluorononanoic acid (PFNA), and perfluorodecanoic acid (PFUA) were 3.49 (0.75-52.2) ng/mL, 8.65 (0.11-85.90) ng/mL, 0.38 (0.38-25.4) ng/mL, and 6.59 (1.50-105.7) ng/mL, respectively. After controlling for age, gender, smoking status, systolic blood pressure, body mass index, low-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, and homeostasis model assessment of insulin resistance, multiple linear regression analysis revealed that CIMT increased significantly across quartiles of PFOS (0.434 mm, 0.446 mm, 0.458 mm, 0.451 mm; P for trend <0.001). Subpopulation analysis showed the association between PFOS and CIMT was more evident and significant in females, non-smokers, subjects of age 12-19 years, BMI <24, and those with APOE genotype of E2 carrier and E3/E3. Conclusions Higher serum concentrations of PFOS were associated with an increase of carotid IMT in this cohort of adolescents and young adults. Further studies are warranted to clarify the causal relationship between PFOS and atherosclerosis.",
keywords = "Carotid intima-media thickness, Perfluorinated chemicals, Perfluorononanoic acid, Perfluorooctane sulfate",
author = "Lin, {Chien Yu} and Lin, {Lian Yu} and Wen, {Ting Wen} and Lien, {Guang Wen} and Chien, {Kuo Liong} and Hsu, {Sandy H J} and Liao, {Chien Chang} and Sung, {Fung Chang} and Chen, {Pau Chung} and Su, {Ta Chen}",
year = "2013",
month = "10",
day = "9",
doi = "10.1016/j.ijcard.2013.04.042",
language = "English",
volume = "168",
pages = "3309--3316",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Association between levels of serum perfluorooctane sulfate and carotid artery intima-media thickness in adolescents and young adults

AU - Lin, Chien Yu

AU - Lin, Lian Yu

AU - Wen, Ting Wen

AU - Lien, Guang Wen

AU - Chien, Kuo Liong

AU - Hsu, Sandy H J

AU - Liao, Chien Chang

AU - Sung, Fung Chang

AU - Chen, Pau Chung

AU - Su, Ta Chen

PY - 2013/10/9

Y1 - 2013/10/9

N2 - Background Perfluorinated chemicals (PFCs) have been widely used for years in a variety of products worldwide. Although epidemiological findings have shown that PFC levels are positively associated with cholesterol and uric acid levels, it is unknown whether PFCs are associated with atherosclerosis. Methods We recruited 664 subjects (12-30 years) from a population-based sample of adolescents and young adults based on a mass urine screening to determine the relationship between serum levels of PFCs and carotid intima-media thickness (CIMT). Results The median concentrations and ranges of perfluorooctanoic acid (PFOA), perfluorooctane sulfate (PFOS), perfluorononanoic acid (PFNA), and perfluorodecanoic acid (PFUA) were 3.49 (0.75-52.2) ng/mL, 8.65 (0.11-85.90) ng/mL, 0.38 (0.38-25.4) ng/mL, and 6.59 (1.50-105.7) ng/mL, respectively. After controlling for age, gender, smoking status, systolic blood pressure, body mass index, low-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, and homeostasis model assessment of insulin resistance, multiple linear regression analysis revealed that CIMT increased significantly across quartiles of PFOS (0.434 mm, 0.446 mm, 0.458 mm, 0.451 mm; P for trend <0.001). Subpopulation analysis showed the association between PFOS and CIMT was more evident and significant in females, non-smokers, subjects of age 12-19 years, BMI <24, and those with APOE genotype of E2 carrier and E3/E3. Conclusions Higher serum concentrations of PFOS were associated with an increase of carotid IMT in this cohort of adolescents and young adults. Further studies are warranted to clarify the causal relationship between PFOS and atherosclerosis.

AB - Background Perfluorinated chemicals (PFCs) have been widely used for years in a variety of products worldwide. Although epidemiological findings have shown that PFC levels are positively associated with cholesterol and uric acid levels, it is unknown whether PFCs are associated with atherosclerosis. Methods We recruited 664 subjects (12-30 years) from a population-based sample of adolescents and young adults based on a mass urine screening to determine the relationship between serum levels of PFCs and carotid intima-media thickness (CIMT). Results The median concentrations and ranges of perfluorooctanoic acid (PFOA), perfluorooctane sulfate (PFOS), perfluorononanoic acid (PFNA), and perfluorodecanoic acid (PFUA) were 3.49 (0.75-52.2) ng/mL, 8.65 (0.11-85.90) ng/mL, 0.38 (0.38-25.4) ng/mL, and 6.59 (1.50-105.7) ng/mL, respectively. After controlling for age, gender, smoking status, systolic blood pressure, body mass index, low-density lipoprotein cholesterol, triglyceride, high-sensitivity C-reactive protein, and homeostasis model assessment of insulin resistance, multiple linear regression analysis revealed that CIMT increased significantly across quartiles of PFOS (0.434 mm, 0.446 mm, 0.458 mm, 0.451 mm; P for trend <0.001). Subpopulation analysis showed the association between PFOS and CIMT was more evident and significant in females, non-smokers, subjects of age 12-19 years, BMI <24, and those with APOE genotype of E2 carrier and E3/E3. Conclusions Higher serum concentrations of PFOS were associated with an increase of carotid IMT in this cohort of adolescents and young adults. Further studies are warranted to clarify the causal relationship between PFOS and atherosclerosis.

KW - Carotid intima-media thickness

KW - Perfluorinated chemicals

KW - Perfluorononanoic acid

KW - Perfluorooctane sulfate

UR - http://www.scopus.com/inward/record.url?scp=84886249620&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886249620&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2013.04.042

DO - 10.1016/j.ijcard.2013.04.042

M3 - Article

VL - 168

SP - 3309

EP - 3316

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 4

ER -